Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression. A prospective analysis
Access status:
Open Access
Type
ArticleAuthor/s
Beesley, VLGreen, AC
Wyld, DK
O'Rourke, P
Wockner, LF
deFazio, A
Butow, PN
Price, MA
Horwood, KR
Clavarino, AM
Date
2014-01-01Publisher
ElsevierLicence
“NOTICE: this is the author’s version of a work that was accepted for publication in Gynecologic Oncology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in, Gynecologic Oncology, 132: 2014, doi: 10.1016/j.ygyno.2013.10.004Citation
Beesley VL, Green AC, Wyld DK, O’Rourke P, Wockner LF, DeFazio A, Butow PN, Price MA, Horwood KR, Clavarino AM, Australian Ovarian Cancer Study Group, Australian Ovarian Cancer Study – Quality of Life Study Investigators, Webb PM. Quality of life and treatment response among women with platinum-resistant versus platinum-sensitive ovarian cancer treated for progression. A prospective analysis. Gynecologic Oncology 2014; 132: 130–136Share